#Chemosensitivity
#Chemoresistance undermines #ColorectalCancer therapy.

YTHDF1 drives stemness & drug resistance by promoting #NOTCH1 translation, while its inhibition restores chemosensitivity, highlighting it as a potential #TherapeuticTarget.

#STTT #OpenAccess: doi.org/10.1038/s413...
November 11, 2026 at 3:15 PM
PRC2 governs HR proficiency and chemosensitivity in ovarian cancer via SQSTM1-mediated chromatin ubiquitination
The authors declare that they have no known competing financial interests or personal relationships that could influence the work reported in this study. Ethics statement Animal studies were conducted in accordance with ethical guidelines approved by the Animal Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. The ethical approval number was 2132. Research involving human biological samples was conducted in compliance with the Declaration of Helsinki and approved by the Research Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China). The ethical approval number was S451. Consent for publication All participants provided written informed consent before their inclusion. The purpose of the research, the procedures involved, and any potential risks or benefits were thoroughly explained to each participant. Participants were informed of their right to withdraw from the study at any time without any consequences. The informed consent process complied with the ethical standards of the Research Ethics Committee of the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China). This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF...
www.nature.com
November 1, 2026 at 12:20 PM
Presenting our latest manuscript out now in
@springernature.com Leukemia journal exploring new biology in RUNX1 aberrant blast-phase CML.

We reveal the RBP SPATS2L is induced by RUNX1 loss impacting CML growth, survival, chemosensitivity & stress granule formation.

www.nature.com/articles/s41...
RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly - Leukemia
Leukemia - RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly
www.nature.com
October 28, 2026 at 12:25 PM
A Copper−Organic Framework Nanozyme Exposes Mitochondrial Vulnerability to Enhance Colorectal Cancer Chemosensitivity https://pubs.acs.org/aanmf6/article/doi/10.1021/acsanm.6c03498/5456067/A-Copper-Organic-Framework-Nanozyme-Exposes
October 23, 2026 at 7:07 PM
4. The RRM domains of PARP14 mediate replication fork degradation in BRCA2-deficient cells - Hale et al. doi.org/10.1093/narc.... How #PARP14 engages nascent DNA and recruits MRE11 to degrade reversed forks in BRCA2-deficient cells. 5/18
The RRM domains of PARP14 mediate replication fork degradation in BRCA2-deficient cells
Abstract. Degradation of reversed replication forks by nucleases has emerged as a major mechanism of chemosensitivity in BRCA-deficient cells. We previousl
doi.org
October 7, 2026 at 1:44 AM
One-carbon metabolism controls colorectal cancer cell state and chemosensitivity through chromatin remodeling https://www.biorxiv.org/content/10.64898/2026.09.30.755690v1
October 2, 2026 at 8:25 AM
One-carbon metabolism controls colorectal cancer cell state and chemosensitivity through chromatin remodeling https://www.biorxiv.org/content/10.64898/2026.09.30.755690v1
October 2, 2026 at 8:25 AM
Dhruva Biswas, et al.: Causal multi-modal AI for personalized chemosensitivity prediction https://arxiv.org/abs/2609.13567 https://arxiv.org/pdf/2609.13567 https://arxiv.org/html/2609.13567
September 16, 2026 at 6:39 AM
Open Access UCL Research: Evaluating the impact of dynamic fluid flow on an advanced model of pancreatic cancer: Towards desmoplasia disruption and chemosensitivity promotion discovery.ucl.ac.uk/id/eprint/10...
Evaluating the impact of dynamic fluid flow on an advanced model of pancreatic cancer: Towards desmoplasia disruption and chemosensitivity promotion - UCL Discovery
UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.
discovery.ucl.ac.uk
September 15, 2026 at 4:16 PM
Dhruva Biswas, et al.: Causal multi-modal AI for personalized chemosensitivity prediction https://arxiv.org/abs/2609.13567 https://arxiv.org/pdf/2609.13567 https://arxiv.org/html/2609.13567
September 15, 2026 at 6:39 AM
#6

Junjie Yu, Youyi Lu, et al. "miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1"
Oncology Reports (2014)
10.3892/or.2013.2897 pubmed: 24317363

submitted here: pubpeer.com/publications...
September 10, 2026 at 12:26 PM
#Infection and #Hypoxia converge on the PHD1–TRIM21–CDC20 axis to drive #Aneuploidy and #Chemoresistance, while CDC20 stabilization limits securin and MCL1 accumulation, reduces chromosomal imbalance, and restores #Chemosensitivity.

#STTT #OpenAccess: doi.org/10.1038/s413...
September 8, 2026 at 7:00 AM
A paper using RRID:AB_3073913 from @proteintech.bsky.social was just published in Cellular Oncology. RRIDs improve reproducibility in scientific research. #accelerateopenscience #methodsmatter #OpenResearch
P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer
Read the full paper: P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer
doi.org
August 28, 2026 at 7:00 AM
⚕️ It may also predict chemosensitivity while improving patient workflow and imaging access

link.springer.com/article/10.1... (Lígia Pires-Gonçalves et al.)
Contrast-enhanced mammography in the setting of neoadjuvant therapy from a multidisciplinary perspective - Insights into Imaging
Abstract Contrast-enhanced mammography (CEM) is a morphofunctional imaging technique that is gaining interest and acceptance in clinical practice. With increasing use of neoadjuvant therapy (NAT) in…
link.springer.com
August 26, 2026 at 8:00 AM
Atypical MDM2 p53 Regulation and Chemosensitivity Induced by Proximal PAS Deletion https://www.biorxiv.org/content/10.64898/2026.08.23.746494v1
August 24, 2026 at 10:46 PM
Atypical MDM2 p53 Regulation and Chemosensitivity Induced by Proximal PAS Deletion https://www.biorxiv.org/content/10.64898/2026.08.23.746494v1
August 24, 2026 at 10:46 PM
Mesenchymal chondrosarcoma (MCS) is characterised by small round cell biology, frequent HEY1-NCOA2 fusion, and high vascularity. These features plausibly lessen extracellular matrix barriers and confer relative chemosensitivity. We aim to provide a clinically-useful review

doi.org/10.3390/curr...
November 6, 2025 at 9:25 PM
fucking chemosensitivity
February 25, 2026 at 8:11 PM
The cyclic growth pattern could influence sensitivity to chemotherapeutics, as these drugs are designed to target pmc.ncbi.nlm.nih.gov/articles/PMC...

link.springer.com/article/10.1...
& the Factors influencing chemosensitivity include the tumor’s immune landscape
February 16, 2025 at 5:52 AM
There are some differences; mostly in vertical stretch, quality, brightness and contrast, the image on PubPeer is quite large and the similarities should be clear: pubpeer.com/publications...
PubPeer - Targeting claudin-4 enhances CDDP-chemosensitivity in gastri...
There are comments on PubPeer for publication: Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer (2019)
pubpeer.com
March 16, 2026 at 10:16 PM
A study using CRISPR gene editing reduced drug-resistance genes in ovarian cancer cells, making them more sensitive to treatment. #CancerResearch #GeneEditing
www.rimpacts.com/rd/p?c=10172...
Crispr/Cas9, a New Approach to Successful Knockdown of Abcb1/P-Glycoprotein and Reversal of Chemosensitivity in Human Epithelial Ovarian Cancer Cell Line
A study using CRISPR gene editing reduced drug-resistance genes in ovarian cancer cells, making them more sensitive to treatment. #CancerResearch #GeneEditing
www.rimpacts.com
October 18, 2025 at 3:38 PM